Arcadia Biosciences (RKDA) AGM 2026 summary

Opening remarks and agenda

• Chair welcomed attendees, introduced board members, and outlined the meeting's agenda and procedures.

• Agenda included director election, stock issuance approval, equity plan, reverse stock split, executive compensation, auditor ratification, and potential adjournment.

Shareholder proposals

• Proposals included electing a Class II director, approving potential stock issuance from a private placement, adopting the 2026 Omnibus Equity Incentive Plan, amending the certificate for a reverse stock split, approving executive compensation, ratifying auditors, and authorizing adjournment if needed.

Corporate governance

• Quorum was confirmed with sufficient shares present in person or by proxy.

• Voting was conducted online and by proxy, with each share entitled to one vote.

• No advance notice of director nominations was received from shareholders.